Pfizer wins Xiapex approval; RXi raising $8.1M; Researcher touts personalized cancer treatment

@FierceBiotech: Aggressive midcap biotechs suit up for the M&A game. Article | Follow @FierceBiotech

@JohnCFierce: Biotech and pharma boundaries will continue to blur. | Follow @JohnCFierce 

> Pfizer has won European approval for Xiapex, Auxilium's therapy for Dupuytren's contracture treatment. Story

> RXi Pharmaceuticals is planning to raise $8.1 million. News

> The FDA has granted Celgene a priority review process for the expanded use of Istodax. Report

> Investigators say that they have found evidence that a rectal gel could be effective in warding off HIV. Story

And Finally... A Wayne State University School of Medicine physician-researcher says he has developed a personalized therapy to treat a wide range of cancers. The treatment is based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves. Release